Venn Diagram MedTech Success – Aligning Product and Business Strategy
In this episode of MedDevice by Design, we explore how the Venn Diagram MedTech Success model helps early-stage companies align product design with commercial strategy. Mark Drlik and Ariana Wilson share how this triple Venn framework, focusing on feasibility, viability, and desirability, can diagnose the strengths and weaknesses of a MedTech product or startup.
What Is the Venn Diagram MedTech Success Model?
The Venn Diagram MedTech Success framework consists of three intersecting pillars:
- Feasibility: Can we build it? Do we have the technical and engineering capability?
- Viability: Can we sell it? Will it generate economic value in a competitive market?
- Desirability: Will users and payers want it? Does it meet clinical and user needs?
Mark emphasizes that while most teams focus heavily on feasibility, overlooking the business and market context can derail an otherwise brilliant product.
Applying the Venn Diagram to Real-World MedTech Devices
Mark uses intravascular lithotripsy—a device designed to break up calcified plaque in arteries—as a real-world example. This innovation checked all three boxes:
- A strong business strategy and regulatory plan (viability)
- A differentiated product that improved safety and effectiveness (desirability)
- A feasible, proven technical path with clinical precedent (feasibility)
By mapping success factors in each area, teams can assess risk early, validate commercial potential, and focus their development investment where it matters most.
Why This Matters in Early-Stage MedTech
The Venn Diagram MedTech Success model is especially useful for startups navigating limited budgets and uncertain markets. It helps founders:
- Prepare for investment pitches
- Avoid over-engineering a product no one wants
- Prioritize features that drive adoption and reimbursement
Whether you’re aiming for acquisition or full commercialization, this framework offers a repeatable, cross-functional approach to building successful medical technologies.
Enjoying MedDevice by Design? Sign up to get new episodes sent to your inbox.
Related Resources
Nick Allan and Nigel Syrotuck explain exactly how aminoglycoside antibiotics work and why they’re so effective at killing bacteria.
Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.
Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.
Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.